Clinical decision support
Also, Remidio receives a CE mark for its AI tool for detecting referable diabetic retinopathy.
It will be based in Amsterdam, the Netherlands.
It seeks to use AI to improve the accuracy of an information-extracting method for structuring radiology reports.
Qure.ai's qXR software will enable Mylab's upcoming x-ray device to quickly detect TB.
Also, Lunit has deployed its AI mammography solution to Dubai Hospital.
It plans to secure more regulatory approvals for its AI pathology platform.
Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.
MediOrbis will incorporate Kahun's AI tool into its platform to provide clinical insights to healthcare providers based on patients’ intake information.
This follows its earlier approvals from the US, Europe, Japan and Taiwan.
Under the multiyear strategic partnership Anumana will conduct a clinical-validation trial and seek FDA De Novo classification for the algorithm.